PT  - JOURNAL ARTICLE
AU  - Götz, Thomas
AU  - Heidrich, Peter
TI  - COVID–19 Disease Dynamics in Germany: First Models and Parameter Identification
AID  - 10.1101/2020.04.23.20076992
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.23.20076992
4099  - http://medrxiv.org/content/early/2020/04/29/2020.04.23.20076992.short
4100  - http://medrxiv.org/content/early/2020/04/29/2020.04.23.20076992.full
AB  - Since the end of 2019 an outbreak of a new strain of coronavirus, called SARS– CoV–2, is reported from China and later other parts of the world. Since January 21, WHO reports daily data on confirmed cases and deaths from both China and other countries [1]. The Johns Hopkins University [5] collects those data from various sources worldwide on a daily basis. For Germany, the Robert–Koch–Institute (RKI) also issues daily reports on the current number of infections and infection related fatal cases [2]. However, due to delays in the data collection, the data from RKI always lags behind those reported by Johns Hopkins. In this work we present an extended SEIR–model to describe the disease dynamics in Germany. The parameter values are identified by matching the model output to the officially reported cases. An additional parameter to capture the influence of unidentified cases is also included in the model.There’s an evil virus that’sthreatening mankind […]A menace to societyIron Maiden, Virus, 1996.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors are fully funded by the state of Rhineland-Palatinate, Germany.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the manuscript are open access.